NAU JEFFREY (President and CEO) received a stock award from OYSTER POINT PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/11/2022ACC: 0001209191-22-002979
DirectorOfficer· President and CEO
Since Oct 2019
+256.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
256.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+46.70K
Price / share
—
Trade value
—
% of position
42.1%
1/9/2022
110.90K→157.60K
Total
Net shares
+46.70K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2022 | A · Award | +46.70K | — | — | 42.1% | 110.90K | 157.60K |
| Total | +46.70K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
210K shares
Shares
+210K
Strike price
16.00
Held after
210K
Exercisable
—
1/9/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock210K shares | 1/9/2022 | A · Award | +210K | 16.00 | — | 210K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1K
Total
1K indirect1K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1K | Indirect |
| Total | 1K | 1K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported